Political economy of generic drug regulation in Latin America

• Grant number: 18/19737-7
• Support Opportunities: Scholarships in Brazil - Scientific Initiation
• Start date: October 01, 2018
• End date: December 31, 2019
• Field of knowledge: Applied Social Sciences - Administration - Public Administration
• Principal Investigator: Elize Massard da Fonseca
• Grantee: Luísa Bolaffi Arantes
• Host Institution: Escola de Administração de Empresas de São Paulo (EAESP). Fundação Getúlio Vargas (FGV). São Paulo , SP, Brazil
• Associated research grant: 15/18604-5 - Policies to increase the competitiveness of the pharmaceutical sector: Brazil's experience, AP.JP
• Associated scholarship(s): 19/08888-7 - Spain's fight against hepatitis C: access to medicines, regionalism, and patents, BE.EP.IC

Abstract

This proposal aims at developing typology for comparing national approaches toward the regulation of generic drugs, and to map out a research strategy for applying this typology in the Latin American. Generic drug substitution may constitute a core instrument of countries' National Pharmaceutical Policies, a way to reduce the price of drugs while expanding access to health care. Yet despite the widely acknowledged importance of policy in this area and observed differences in national practices, scholars embarking on comparative analysis lack a roadmap of which dimensions of generic drug policy to assess/compare. We aim to fill that gap. The student will assist in mapping national regulations, collecting data on international guidelines for harmonization drug regulation (desk research), and assist on scheduling and conducting in-depth interviews with specialists.